Toni K. Choueiri, MD, on Urothelial Cancer: Trial Results From Borealis-2

2017 Genitourinary Cancers Symposium
Tweet this page

Toni K. Choueiri, MD, of the Dana-Farber Cancer Institute, discusses study findings on apatorsen plus docetaxel vs docetaxel alone in platinum-resistant metastatic urothelial cancer. (Abstract 289)

Advertisement

Advertisement



Advertisement